# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Diana, Princess of Wales (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML028-SYN
- Date: 2026-02-16
- Fictional facility: St. Posthumous Health Center
- Fictional author: Imogen Castleford, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

One-week review with potassium recheck, seen the same day by eating disorders psychiatry. **S**

## History of present illness

Ms. Spencer returns one week after her first visit and is seen by Dr. Rosenthal, the eating disorders psychiatrist, on the same day. She has taken potassium chloride 20 mEq twice daily without stomach upset. She has kept the self-monitoring record she was given: seven episodes of binge eating with vomiting this week, from about ten, and breakfast on three days. She has met the dietitian once. She has had no palpitations, cramps, weakness, dizziness, or blood in the vomit. Her mood is still low and she is tired, but she says that telling someone has been a relief. She has had no thoughts of suicide or self-harm. **S**

| Element | Detail |
|---|---|
| Binge eating and vomiting | Seven episodes this week, from about ten |
| Potassium supplement | 20 mEq twice daily, every dose taken |
| Regular eating | Breakfast on three days; dietitian seen once |
| Mood | Low; PHQ-9 13; item 9 scored 0 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired in the mornings; weight steady |
| Cardiovascular | Negative | No palpitations, chest pain, or fainting |
| Gastrointestinal | Positive | Vomiting after binges seven times this week; no blood in the vomit; no abdominal pain |
| Musculoskeletal | Negative | No cramps or weakness |
| Psychiatric | Positive | Low mood and hopelessness, a little better; no thoughts of suicide or self-harm |

5 systems reviewed. **S**

## Current medications

- Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with food **S**
- Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one week **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/66 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 99% on room air; weight 61.2 kg; BMI 19.3 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 3.6 mmol/L; Chloride: 99 mmol/L; Bicarbonate (total CO2): 28 mmol/L; Creatinine: 0.8 mg/dL; eGFR: 103 mL/min/1.73 m²; PHQ-9: 13. All results are synthetic.

## Change since baseline

- Sodium: 137 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 3.1 mmol/L (low) at baseline, 3.6 mmol/L at this visit **S**
- Chloride: 94 mmol/L (low) at baseline, 99 mmol/L at this visit **S**
- Bicarbonate (total CO2): 32 mmol/L (high) at baseline, 28 mmol/L at this visit **S**
- Creatinine: 0.84 mg/dL at baseline, 0.8 mg/dL at this visit **S**
- eGFR: 97 mL/min/1.73 m² at baseline, 103 mL/min/1.73 m² at this visit **S**
- PHQ-9: 14 at baseline, 13 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 61.2 kg, BMI 19.3; lying blood pressure 104/66 and pulse 68, standing 100/64 and pulse 84 after three minutes |
| Head and neck | Both parotid glands enlarged and non-tender, as before; enamel erosion on the inner surfaces of the upper front teeth |
| Skin | Small calluses on the backs of two knuckles of the right hand |
| Psychiatric | Tearful at times but engaged; organized; no psychotic features; insight good |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypokalemia from vomiting** (E87.6). Potassium 3.6 mmol/L, from 3.1, on oral replacement with a little less vomiting; chloride 99 and bicarbonate 28 mmol/L, creatinine 0.80 mg/dL. Normal once; one more normal check is needed before the supplement stops. **S**
   - Continue potassium chloride 20 mEq twice daily.
   - Electrolytes again at the next visit.
2. **Bulimia nervosa, severe** (F50.23). Seven episodes a week, still in the severe range. Dr. Rosenthal agrees with the diagnosis and that outpatient care is safe: potassium is improving, the QTc was 452 ms at intake, the pulse rise on standing is 16 per minute, and she is not fainting. She advises eating-disorder-focused CBT (CBT-E) rather than guided self-help because the illness is severe and has lasted years, and fluoxetine from the start because of its severity and her depression. **S**
   - CBT-E with the eating disorders therapist: 20 sessions over 20 weeks, twice weekly for the first four weeks, starting this week.
   - Start fluoxetine 20 mg each morning, 40 mg after one week, and 60 mg after two weeks.
   - Nurse phone check in ten days for side effects, agitation, and suicidal thoughts.
   - ECG two weeks after reaching 60 mg.
3. **Major depressive disorder, recurrent, moderate** (F33.1). PHQ-9 13, from 14. Fluoxetine will treat the depression as well. Safety reviewed: no thoughts of suicide or self-harm; the safety plan and the 988 Suicide & Crisis Lifeline are in her phone; no firearm. **S**
   - Call the clinic or 988 for any new agitation, restlessness, or thoughts of self-harm after starting fluoxetine.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Binge-eating and vomiting frequency (her self-monitoring record) | Every visit | Completed today | Seven episodes of binge eating with vomiting this week, from about ten |
| Survey | Eating Disorder Examination Questionnaire (EDE-Q) global score | Baseline, mid-treatment, and end of treatment | Up to date | Global score 3.9 at intake; repeat at mid-treatment |
| Examination | Weight and BMI | Every visit, and weekly in CBT-E sessions | Completed today | 61.2 kg, BMI 19.3 |
| Examination | Lying and standing pulse and blood pressure | Every visit while purging continues | Completed today | Lying 104/66, pulse 68; standing 100/64, pulse 84 (rise 16) |
| Laboratory | Potassium, chloride, bicarbonate, and creatinine | Weekly until potassium is normal twice, then at each medical visit while purging continues | Completed today | Potassium 3.6 mmol/L, from 3.1; sodium 139, chloride 99, bicarbonate 28 mmol/L; creatinine 0.80 mg/dL, eGFR 103 |
| Laboratory | Magnesium and phosphate | Baseline, and again while potassium is low | Up to date | Magnesium 1.8 and phosphate 3.4 mg/dL at intake; magnesium again at the next visit |
| Laboratory | ECG with QTc | Baseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been low | Due | QTc 452 ms at intake; repeat two weeks after reaching fluoxetine 60 mg |
| Examination | Parotid and dental examination; dental protection | Every visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continues | Due | Parotid enlargement and enamel erosion unchanged; dental examination advised at intake, not yet booked |
| Medication safety | Oral potassium supplement | While potassium is low or vomiting is frequent | Completed today | 20 mEq twice daily, every dose taken; continue until a second normal check |
| Medication safety | Fluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts) | At the start, one to two weeks after starting or a dose change, then every visit | Completed today | Starting today at 20 mg; side effects, agitation and suicidal thoughts explained; nurse phone check in ten days |
| Referral | Eating disorders psychiatry consultation | At diagnosis | Completed today | Seen by Dr. Rosenthal today |
| Self-management | CBT-E attendance and progress | Up to 20 sessions over 20 weeks, twice weekly for the first four weeks | Ordered | CBT-E starts this week |
| Self-management | Regular eating and dietitian review | Every visit | Completed today | Breakfast on three days; dietitian seen once |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, then periodically | Completed today | PHQ-9 13, item 9 scored 0 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan reviewed; no firearm |
| Examination | Level-of-care review against thresholds for urgent or inpatient care | Every visit | Completed today | Outpatient care remains safe: potassium above 3.0 mmol/L, QTc below 500 ms, no fainting, pulse above 50 |

## Goal progress

- No binge eating or vomiting for at least four weeks by the end of 20 weeks of CBT-E. In progress; target 2026-07-13. **S**
- Potassium at least 3.5 mmol/L on two checks within four weeks. In progress; target 2026-03-16. **S**
- Regular eating (three meals and two or three snacks) on most days by three months. In progress; target 2026-05-11. **S**
- PHQ-9 score below 5 by the end of treatment. In progress; target 2026-07-13. **S**
- EDE-Q global score below 2.0 by the end of treatment. In progress; target 2026-07-13. **S**

## Medication changes

- Started: Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one week **S**

## Guideline basis

- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023), American Psychiatric Association (American Journal of Psychiatry 2023;180(2):167-171)
- Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020), National Institute for Health and Care Excellence
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge

## Follow-up

- CBT-E twice weekly from this week. Nurse phone check in ten days. Visit in four weeks with electrolytes, magnesium, ECG, and the PHQ-9. **S**
- Next scheduled visit 2026-03-16: five-week review: potassium and ECG on fluoxetine 60 mg, CBT-E progress, mood, and safety. **S**
